Carregant...
Changing strategies for target therapy in gastric cancer
In spite of a worldwide decrease in the incidence of gastric cancer, this malignancy still remains one of the leading causes of cancer mortality. Great efforts have been made to improve treatment outcomes in patients with metastatic gastric cancer, and the introduction of trastuzumab has greatly imp...
Guardat en:
| Publicat a: | World J Gastroenterol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Baishideng Publishing Group Inc
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4716029/ https://ncbi.nlm.nih.gov/pubmed/26811656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i3.1179 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|